Document Detail

Why did high-dose rosuvastatin not improve cardiac remodeling in chronic heart failure? Mechanistic insights from the UNIVERSE study.
MedLine Citation:
PMID:  20085851     Owner:  NLM     Status:  In-Data-Review    
BACKGROUND: Statins are often prescribed for prevention of atherosclerotic outcomes in patients who have chronic heart failure (CHF), if this has an ischaemic etiology. These agents may also possess additional properties, independent of effects on blood lipid levels, which may have an effect on cardiac remodeling. However, beneficial effects were not observed in the recent UNIVERSE trial.
METHODS: We prospectively planned a sub-study of UNIVERSE to explore relevant mechanistic effects of rosuvastatin, including effects on collagen turnover and plasma coenzyme Q10 (CoQ) levels. Additionally, CoQ levels in CHF patients receiving chronic statin therapy were measured.
RESULTS: CoQ levels were significantly reduced after 26weeks of rosuvastatin statin therapy (n=32), compared to placebo (n=37) in CHF patients in UNIVERSE trial. Patients with CHF (n=56) matched for age, gender and severity of disease who had been taking statins for 12months or longer had CoQ levels of 847±344nmol/L, significantly lower than 1065.4±394nmol/L in UNIVERSE patients at baseline (p=0.0001). Serum types I and III N-terminal procollagen peptide (PINP and PIIINP), measures of collagen turnover which can contribute to cardiac fibrosis were significantly increased in the rosuvastatin group compared to baseline in UNIVERSE patients (PINP: p=0.03, PIIINP: p=0.001).
CONCLUSION: In conclusion putative beneficial effects of statin therapy on cardiac remodeling in UNIVERSE may have been negated by increases in collagen turnover markers as well as a reduction in plasma CoQ levels in these patients with CHF.
Emma Ashton; Emma Windebank; Marina Skiba; Christopher Reid; Hans Schneider; Franklin Rosenfeldt; Andrew Tonkin; Henry Krum
Publication Detail:
Type:  Journal Article     Date:  2010-01-20
Journal Detail:
Title:  International journal of cardiology     Volume:  146     ISSN:  1874-1754     ISO Abbreviation:  Int. J. Cardiol.     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-01-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8200291     Medline TA:  Int J Cardiol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  404-7     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.
Department of Health Science, Monash University, Frankston Vic 3119, Melbourne, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Characterisation of the prodrome to a first episode of psychotic mania: Results of a retrospective s...
Next Document:  Evaluation of an alcohol-based power sanitizing system for decontamination of hospital rooms of pati...